Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: A diffusion tensor imaging study

Dementia and Geriatric Cognitive Disorders

Volumn 18, Issue 1, 2004, Pages 101-108

  Fellgiebel, A ^a   Wille, P ^a   Muller M J ^a   Winterer, G ^a   Scheurich, A ^a   Vucurevic, G ^a   Schmidt, L G ^a   Stoeter, P ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Diffusion tensor imaging; Mild cognitive impairment; Neurodegenerative disease

Indexed keywords

AGED; ANISOTROPY; ARTICLE; BRAIN REGION; BRAIN TISSUE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FEMALE; HIPPOCAMPUS; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ULTRASTRUCTURE; WHITE MATTER;

AGED; ALZHEIMER DISEASE; ANISOTROPY; BRAIN; COGNITION DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 3042647180     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077817     Document Type: Article

References (51)

1. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L: Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
2. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-308.
3. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
4. De Santi S, De Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, Tsui WH, Kandil E, Boppana M, Daisley K, Wang GJ, Schlyer D, Fowler J: Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001;22:529-539.
5. Andreasen N, Minthon L, Vanmechelen E, Vanderstichele H, Davidsson P, Winblad B, Blennow K: Cerebrospinal fluid tau and Aβ42 as predictor of development of Alzheimer's disease in patients with mild cognitive impairment. Neurosci Lett 1999;273:5-8.
6. Arai H, Ishiguro K, Ohno H, Moriyama M, Itoh N, Okamura N, Matsui T, Morikawa Y, Horikawa E, Kohno H, Sasaki H, Imahori K: CSF phosphorylated tau protein and mild cognitive impairment: A prospective study. Exp Neurol 2000;166:201-203.
7. 1-42 levels in the mild cognitive impairment stage of Alzheimer's disease. Exp Neurol 2001;172:433-436.
8. Riemenschneider M, Lautenschlager N, Wagenpfeil S, Diehl J, Drzezga A, Kurz A: Cerebrospinal fluid tau and β-amyloid 42 proteins identify Alzheimer disease subjects with mild cognitive impairment. Arch Neurol 2002;59:1729-1734.
9. Huang C, Wahlund L, Dierks T, Julin P, Winblad B, Jelic V: Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: A cross-sectional and longitudinal study. Clin Neurophysiol 2000;111:1961-1967.
10. Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO: Quantitative electroencephalography in mild cognitive impairment: Longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging 2000;21:533-540.
11. De Leon MJ, Convit A, De Santi S, Bobinski M, George AE, Wisniewski HM, Rusinek H, Carroll R, Saint Louis LA: Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease. Int Psychogeriatr 1997; 9(suppl 1):183-190.
12. Grundman M, Sencakova D, Jack CR Jr, Petersen RC, Kim HT, Schultz A, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Thomas RG, Thal LJ: Alzheimer's disease cooperative study: Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci 2002;19:23-27.
13. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-1403.
14. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS: MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002;58:1188-1196.
15. Ouchi Y, Nobezawa S, Okada H, Yoshikawa E, Futatsubashi M, Kaneko M: Altered glucose metabolism in the hippocampal head in memory impairment. Neurology 1998;51:136-142.
16. Berent S, Giordani B, Foster N, Minoshima S, Lajiness-O'Neill R, Koeppe R, Kuhl DE: Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J Psychiatr Res 1999;33:7-16.
17. Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, Albert MS: Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-1571.
18. Van der Flier WM, Van den Heuvel DM, Weverling-Rijnsburger AW, Spilt A, Bollen EL, Westendorp RG, Middelkoop HA, Van Buchem MA: Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology 2002;59:874-879.
19. Van der Flier WM, Van den Heuvel DM, Weverling-Rijnsburger AW, Bollen EL, Westendorp RG, Van Buchem MA, Middelkoop HA: Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 2002;52:62-67.
20. Basser PJ, Mattiello J, Le Bihan D: Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994;103: 247-254.
21. Basser PJ, Pierpaoli C: A simplified method to measure the diffusion tensor from seven MR images. Magn Reson Med 1998;39:928-934.
22. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H: Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001;13:534-546.
23. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G: Diffusion tensor MR imaging of the human brain. Radiology 1996;201:637-648.
24. Nusbaum AO, Tang CY, Buchsbaum MS, Wei TC, Atlas SW: Regional and global changes in cerebral diffusion with normal aging. AJNR Am J Neuroradiol 2001;22:136-142.
25. Pfefferbaum A, Sullivan EV, Hedehus M, Lim KO, Adalsteinsson E, Moseley M: Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med 2000; 44:259-268.
26. Sullivan EV, Adalsteinsson E, Hedehus M, Ju C, Moseley M, Lim KO, Pfefferbaum A: Equivalent disruption of regional white matter microstructure in ageing healthy men and women. Neuroreport 2001;12:99-104.
27. Bozzali M, Franceschi M, Falini A, Pontesilli S, Cercignani M, Magnani G, Scotti G, Comi G, Filippi M: Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 2001;57:1135-1137.
28. Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, Comi G, Filippi M: White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002;72:742-746.
29. Hanyu H, Sakurai H, Iwamoto T, Takasaki M, Shindo H, Abe K: Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J Neurol Sci 1998;156:195-200.
30. Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, Semple J, Doddrell DM: Loss of connectivity in Alzheimer's disease: An evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 2000;69:528-530.
31. Takahashi S, Yonezawa H, Takahashi J, Kudo M, Inoue T, Tohgi H: Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 tesla magnetic resonance imaging. Neurosci Lett 2002;332:45-48.
32. Yoshiura T, Mihara F, Ogomori K, Tanaka A, Kaneko K, Masuda K: Diffusion tensor in posterior cingulate gyrus: Correlation with cognitive decline in Alzheimer's disease. Neuroreport 2002;13:2299-2302.
33. Brilliant M, Hughes L, Anderson D, Ghobrial M, Elble R: Rarefied white matter in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 1995;9:39-46.
34. Englund E: Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1998; 9(suppl 1):6-12.
35. Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC: Mild cognitive impairment and Alzheimer disease: Regional diffusivity of water. Radiology 2001;219:101-107.
36. Kantarci K, Xu Y, Shiung MM, O'Brien PC, Cha RH, Smith GE, Ivnik RJ, Boeve BF, Edland SD, Kokmen E, Tangalos EG, Petersen RC, Jack CR Jr: Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14:198-207.
37. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
38. Morris JC: The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993;43:2412-2414.
39. Thalmann B, Monsch A, Schneitter M: CERAD neuropsychological battery: A minimal data set to be used as a common assessment tool of dementia. Neurobiol Aging 1998;19:S9.
40. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). 5. A normative study of the neuropsychological battery. Neurology 1994;44:609-614.
41. Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Payer F, Freidl W, Niederkorn K, Lechner H: Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter: A comparative study between stroke patients and normal volunteers. Arch Neurol 1992;49:825-827.
42. Hunsche S, Moseley ME, Stoeter P, Hedehus M: Diffusion-tensor MR imaging at 1.5 and 3.0 tesla: Initial observations. Radiology 2001;221:550-556.
43. Braak H, Griffing K, Braak E: Neuroanatomy of Alzheimer's disease. Alzheimer's Res 1997;3:235-247.
44. Brun A, Englund E: A white matter disorder in dementia of Alzheimer type: A pathoanatomical study. Ann Neurol 1986;19:253-262.
45. Bradley KM, O'Sullivan VT, Soper ND, Nagy Z, King EM, Smith AD, Shepstone BJ: Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease. Brain 2002;125:1772-1781.
46. Nagy Z, Hindley NJ, Braak H, Braak E, Yilmazer-Hanke DM, Schultz C, Barnetson L, King EM, Jobst KA, Smith AD: The progression of Alzheimer's disease from limbic regions to the neocortex: Clinical, radiological and pathological relationships. Dement Geriatr Cogn Disord 1999;10:115-120.
47. Arnaiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, Nordberg A: Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001;12:851-855.
48. Lautenschlager NT, Riemenschneider M, Drzezga A, Kurz AF: Primary degenerative mild cognitive impairment: Study population, clinical, brain imaging and biochemical findings. Dement Geriatr Cogn Disord 2001;12:379-386.
49. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD: Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999;354:919-920.
50. Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, Lamanna JC, Friedland RP, Cotman CW: Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann NY Acad Sci 2002;977:45-64.
51. Borroni B, Akkawi N, Martini G, Colciaghi F, Prometti P, Rozzini L, Di Luca M, Lenzi GL, Romanelli G, Caimi L, Padovani A: Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci 2002;203-204:189-193.